Powerful Antidepressant to Tackle Trauma Condition
National trial will pit
Effexor
against post traumatic stress disorder
Feb. 27, 2002 (HealthScoutNews) -- Researchers
are launching a national study to determine if a powerful antidepressant
will help people suffering from post
traumatic stress disorder, a harrowing condition that stubbornly
resists drug treatment.
Effexor, a sibling of the well-known antidepressant Prozac,
may give doctors the weapon they need against
post-traumatic stress disorder (PTSD), says Dr. David M.
Goldstein, who is overseeing a part of the clinical trial at Georgetown
University Medical Center.
Currently, "we don't have a treatment
that's anywhere near as good as those for other psychiatric conditions,"
he says.
PTSD has been a part of the formal vocabulary
of psychology for only about 20 years, but its effects have long been known
among people who survive traumatic events like war, accidents and violence.
Sufferers report a variety of symptoms, including flashbacks, depression,
anxiety, emotional numbness and panic attacks.
In many cases, sufferers feel constantly on
alert, an obsessive sense of vigilance that can rob people of sleep and
sabotage their personal relationships.
The federal government has approved two
antidepressants, Paxil and Zoloft, for the treatment of PTSD. Both drugs are in
the same class as Prozac, which is not as popular as a treatment for PTSD
because it sometimes raises anxiety levels, Goldstein explains.
But neither Paxil nor Zoloft has a high success
rate at easing PTSD, Goldstein says.
"The level of efficacy is mild to
moderate," he says. "They were approved probably because there's
nothing else that was really demonstrated to be that effective."
By contrast, he says, "we have very good
treatments for depression that (alleviate) symptoms probably 70 percent of the
time. And you can stop panic attacks 80 percent of the time."
In addition to antidepressants, doctors treat
PTSD with a variety of psychiatric drugs, including anti-convulsants and
tranquilizers.
As part of a 15-week nationwide trial funded by
Wyeth Ayerst -- the maker of Effexor -- which will involve 500 people,
Georgetown University is recruiting 10 to 20 PTSD sufferers to see if the drug
reduces their symptoms. Some will receive doses of Effexor, while others will
get Zoloft or a placebo.
Doctors can already prescribe Effexor for PTSD,
although it is not officially approved for that use. Doctors report the success
rate of Effexor appears to be higher than the usual 50 percent when other drugs
are used, Goldstein says. The drug increases levels of the brain chemicals
serotonin and norepinephrine, while Zoloft and other antidepressants only raise
the levels of serotonin in the brain.
Effexor is currently approved for the treatment
of depression and anxiety.
Even when drug treatment is successful, it
doesn't make PTSD disappear, says Esther Giller, director of the Sidran
Traumatic Stress Institute in Baltimore.
"The symptoms of PSTD are so disruptive,
intrusive and problematic for people that very often they can't attend to the
issues of therapy without something to lessen those symptoms," she says.
"(Drug treatment) is a first line of attack, but it's really not a cure.
It's a management tool."
Some people resist the idea of medication, and
must find alternative ways to reduce their levels of physical and mental
stress, she says. "There are non-pharmaceutical techniques to control,
manage and learn to live with those various symptoms."
What To Do
Learn more about PTSD from the
Sidran Traumatic Stress
Institute.
You can also learn more from the
National Center for PTSD.
top ~ next ~
send page to a
friend
HealthyPlace.com
Depression Center Links
home ~ site map ~
causes ~ types ~
people ~
living with
treatments ~ self-help ~ support ~ suicide ~ related
issues
|